Syndax Pharmaceuticals, Inc. ( SNDX) - Key Metrics
SNDX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.79 | -$0.79 | -$0.80 | -$0.80 |
| 2025Q3 | $0.53 | -$0.70 | -$0.81 | -$0.82 |
| 2025Q2 | $0.44 | -$0.83 | -$1.02 | -$1.02 |
| 2025Q1 | $0.23 | -$0.99 | -$1.11 | -$1.11 |
SNDX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -6.69 |
| 2025Q3 | ? | -5.49 |
| 2025Q2 | ? | -2.81 |
| 2025Q1 | ? | -3.10 |
SNDX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -2.49% | ? |
| 2025Q4 | -3.82% | ? |
| 2025Q3 | -5.30% | ? |
| 2025Q2 | -10.85% | ? |
| 2025Q1 | -9.04% | ? |
SNDX
Price: $18.48
52 week price:
Earnings Per Share: -2.79 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 44479
Ebitda: -15.3 millionMarket Capitalization: 1.6 billion